US4781601046 - Common Stock
JOHNSON & JOHNSON
NYSE:JNJ (7/26/2024, 7:04:00 PM)
After market: 160.9 +0.26 (+0.16%)160.64
+1 (+0.63%)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 131,900 full-time employees. The firm's primary focus is products related to human health and well-being. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick NEW JERSEY 08933
P: 17325242455
CEO: A. Gorsky
Employees: 131900
Website: https://www.jnj.com/
Johnson & Johnson lost its bid in a federal appeals court to revive a plan to settle tens of thousands of talc cancer lawsuits by placing a subsidiary into bankruptcy.
Unforced errors by each of these controversial stocks has sullied their reputations and recovering them will not be easy or cheap.
Here you can normally see the latest stock twits on JNJ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: